Radovi istraživača / Researchers’ publications: Recent submissions
Приказ резултата 21-40 од 5175
-
Complex global dynamics of conditionally stable slopes: effect of initial conditions
(Frontiers Media, 2024) -
Acetamiprid's degradation products and mechanism: Part II – Inert atmosphere and charge storage
(Elsevier B.V., 2024) -
Exploring fullerene derivatives for optoelectronic applications: synthesis and characterization study
(Royal Society of Chemistry, 2024) -
The Comparative Analysis of the Impact of N-Acetyl-L-Cysteine and its Combination with Propolis on Quality-of-Life in Patients with Acute Bronchitis
(Association of Pharmaceutical Teachers of India, 2024) -
Intraoral administration of probiotics and postbiotics: An overview of microorganisms and formulation strategies
(Faculdade de Ciencias Farmaceuticas, 2024) -
What is the Current Clinical Impact of the CYP2CTG Haplotype?
(John Wiley and Sons Inc, 2024) -
Novel chitosan and N-isopropylacrylamide-grafted-dextran-based microformulations as effective oral drug delivery system
(Journal of the Iranian Chemical Society, 2024) -
Human papillomaviruses and cervical cancer from the perspective of the World Health Organisation initiative for cervical cancer elimination / Humani papilomavirusi i karcinom grlića materice iz perspektive inicijative Svetske zdravstvene organizacije za eliminaciju karcinoma grlića materice
(Beograd : Savez farmaceutskih udruženja Srbije, 2024) -
Association of catechol-O-methyltransferase gene polymorphisms with treatment response and levodopa-induced complications in Parkinson's disease: A summary of current knowledge / Udruženost polimorfizama gena za katehol-O- metiltransferazu sa terapijskim odgovorom i komplikacijama izazvanim levodopom kod Parkinsonove bolesti: Rezime sadašnjih saznanja
(Beograd : Savez farmaceutskih udruženja Srbije, Beograd : Univerzitet u Beogradu - Farmaceutski fakultet, 2024) -
The impact of the aqueous phase on the physicochemical characteristics of nanoemulsions loaded with patent protected compound GL-II-73
(International Society of Drug Delivery Sciences and Technology (APGI), International Association for Pharmaceutical Technology (APV), Italian Society of Technology and Legislation (S.T.E.L.F), 2024) -
Factors associated with hematological adverse reactions of drugs authorized via the centralized procedure
(Nature Portfolio, 2024)